ATE221073T1 - Neue iridoidderivate und neovaskularisations- inhibitoren die diese als aktviven inhaltstoff enthalten - Google Patents

Neue iridoidderivate und neovaskularisations- inhibitoren die diese als aktviven inhaltstoff enthalten

Info

Publication number
ATE221073T1
ATE221073T1 AT97905448T AT97905448T ATE221073T1 AT E221073 T1 ATE221073 T1 AT E221073T1 AT 97905448 T AT97905448 T AT 97905448T AT 97905448 T AT97905448 T AT 97905448T AT E221073 T1 ATE221073 T1 AT E221073T1
Authority
AT
Austria
Prior art keywords
vascularization
contain
active ingredients
iridoid derivatives
neovascularization inhibitors
Prior art date
Application number
AT97905448T
Other languages
English (en)
Inventor
Hideaki Morishige
Yukiko Kurita
Yousuke Yamazaki
Chiaki Sakakibara
Masaharu Kigawa
Original Assignee
Tsumura & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tsumura & Co filed Critical Tsumura & Co
Application granted granted Critical
Publication of ATE221073T1 publication Critical patent/ATE221073T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/94Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT97905448T 1996-03-06 1997-03-05 Neue iridoidderivate und neovaskularisations- inhibitoren die diese als aktviven inhaltstoff enthalten ATE221073T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP7541996 1996-03-06
PCT/JP1997/000675 WO1997032868A1 (en) 1996-03-06 1997-03-05 Novel iridoid derivatives and neovascularization inhibitors containing the same as active ingredient

Publications (1)

Publication Number Publication Date
ATE221073T1 true ATE221073T1 (de) 2002-08-15

Family

ID=13575660

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97905448T ATE221073T1 (de) 1996-03-06 1997-03-05 Neue iridoidderivate und neovaskularisations- inhibitoren die diese als aktviven inhaltstoff enthalten

Country Status (9)

Country Link
US (1) US6022888A (de)
EP (1) EP0889041B1 (de)
KR (1) KR19990087526A (de)
AT (1) ATE221073T1 (de)
AU (1) AU717878B2 (de)
CA (1) CA2248725A1 (de)
DE (1) DE69714230T2 (de)
ES (1) ES2180936T3 (de)
WO (1) WO1997032868A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6486197B1 (en) * 1997-11-11 2002-11-26 The Kitasato Institute Substance ft-0554 and process for producing the same
AUPR001000A0 (en) * 2000-09-08 2000-10-05 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
US20110217394A1 (en) * 2000-12-05 2011-09-08 Brett Justin West Iridoid Based Formulations
US8790727B2 (en) * 2000-12-05 2014-07-29 Tahitian Noni International, Inc. Morinda citrifolia and iridoid based formulations
WO2003086178A2 (en) * 2002-04-11 2003-10-23 Children's Medical Center Corporation Methods for inhibiting vascular hyperpermeability
AU2003230852B2 (en) * 2002-04-11 2008-07-10 Children's Medical Center Corporation TNP-470 polymer conjugates and use thereof
WO2004089926A2 (en) 2003-03-31 2004-10-21 Beth Israel Deaconess Medical Center, Inc. Genipin derivatives and uses thereof
US20050222053A1 (en) * 2003-10-31 2005-10-06 Health Research, Inc. Iridoid-saccharide compound and method of using same
US20080032939A1 (en) * 2004-10-28 2008-02-07 Health Research, Inc. Iridoid-saccharide compound and method of using same
WO2006084054A2 (en) * 2005-02-02 2006-08-10 Children's Medical Center Corporation Method of treating angiogenic diseases
JP5142311B2 (ja) * 2006-10-26 2013-02-13 小林製薬株式会社 ゲニポシド酸誘導体
WO2009137335A1 (en) * 2008-05-05 2009-11-12 The Scripps Research Institute Synthesis of (+) corstistatin a and related compounds
US20120021079A1 (en) * 2010-02-23 2012-01-26 Brett Justin West Garcinia Mangostana L. and Iridoid Based Formulations
US20110206786A1 (en) * 2010-02-23 2011-08-25 Brett Justin West Acai and Iridoid Based Formulations
WO2014165023A1 (en) * 2013-03-12 2014-10-09 Carnegie Mellon University Coated vaso-occclusive device for treatment of aneurysms
FR3003860B1 (fr) * 2013-03-29 2015-11-27 Oreal Composes derives d'iridoides proteges ou non, composition les comprenant, utilisation comme colorant des fibres keratiniques et dispositifs
CN104892562B (zh) * 2015-06-16 2017-03-15 吴虹 抑制环氧化酶‑2的化合物及其制备方法和应用
CN107400128B (zh) * 2017-07-27 2020-03-31 贵州省中国科学院天然产物化学重点实验室 拟单萜吲哚生物碱及其制备方法和应用
US20190110804A1 (en) 2017-10-16 2019-04-18 Michael Bruce Horowitz Catheter based retrieval device with proximal body having axial freedom of movement
CA3195810A1 (en) 2017-10-16 2022-04-21 Michael Bruce Horowitz Clot removal methods and devices with multiple independently controllable elements
US12201315B2 (en) 2017-10-16 2025-01-21 Retriever Medical, Inc. Clot removal methods and devices with multiple independently controllable elements
EP4196085A4 (de) * 2020-08-12 2025-01-01 inkbox ink Inc. Semipermanente tätowierungen
KR20240121791A (ko) * 2021-12-07 2024-08-09 잉크박스 잉크 인코포레이티드 피부에 부착 가능한 화합물
CN115572278B (zh) * 2022-11-21 2023-09-01 北京志道生物科技有限公司 京尼平衍生物及其制备方法和应用
CN118834253B (zh) * 2024-06-25 2025-03-18 南开大学 京尼平苷衍生物和京尼平衍生物及其制备方法与应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617555C3 (de) * 1966-04-19 1974-09-19 Kali-Chemie Ag, 3000 Hannover Verfahren zur Isolierung von therapeutisch wertvollen Isovaleriansäureestern aus Valeriana- und Kentranthus-Extrakten
US4205083A (en) * 1968-03-30 1980-05-27 Kali-Chemie Aktiengesellschaft Cyclopentapyrans
DE3026579A1 (de) * 1980-07-14 1982-02-11 Kali-Chemie Pharma Gmbh, 3000 Hannover 2,9-dioxatricyclo (4,3,1,o(pfeil hoch)3,7(pfeil hoch)) decane
US4954496A (en) * 1988-08-12 1990-09-04 Fujisawa Pharmaceutical Company, Ltd. Cyclohexane derivatives and pharmaceutical compositions
KR927003493A (ko) * 1990-10-09 1992-12-18 주식회사 쓰무라 이리도이드 유도체 및 그의 의약으로서의 사용
KR100218052B1 (ko) * 1992-07-15 1999-09-01 이병언 B형 간염 바이러스의 복제를 억제하는 약학적 제제

Also Published As

Publication number Publication date
EP0889041B1 (de) 2002-07-24
DE69714230D1 (de) 2002-08-29
KR19990087526A (ko) 1999-12-27
DE69714230T2 (de) 2003-03-27
US6022888A (en) 2000-02-08
ES2180936T3 (es) 2003-02-16
AU717878B2 (en) 2000-04-06
WO1997032868A1 (en) 1997-09-12
CA2248725A1 (en) 1997-09-12
AU2231797A (en) 1997-09-22
EP0889041A4 (de) 2000-08-23
EP0889041A1 (de) 1999-01-07

Similar Documents

Publication Publication Date Title
DE69714230D1 (de) Neue iridoidderivate und neovaskularisations-inhibitoren die diese als aktviven inhaltstoff enthalten
NO960393L (no) Heterosykliske fenylforbindelser som COX-2-inhibitorer
BR0115411A (pt) Combinações sinergìsticas compreendendo um inibidor de renina para doenças cardiovasculares
ATE153855T1 (de) Zusammensetzungen zur behandlung von glaukoma die prostaglandine und clonidinderivate enthalten
NO950297D0 (no) Prolinamidderivater
IS4695A (is) (Metýlsúlfónýl)fenýl-2-(5H)-fúranón sem sýklóoxýgenasa-2 tálmar
NO960380L (no) Middel til behandling av neurosykdommer
DE69716810D1 (de) 2,3-Disubstituierte-(5,6)-heteroarylkondensierte-pyrimidin-4-one
NO985864L (no) Nye anti-virale forbindelser
EP1208092A4 (de) Sulfonamide als matrix-metalloproteinase inhibitoren
EP0699439A3 (de) Behandlung von durch Talgdrüse verursachten Erkrankungen mit Inhibitoren der Acyl CoA Cholesterin Acyltransferase
DE69834500D1 (de) Xanthinderivative zur behandlung von hirnischämie
ATE128459T1 (de) Sulfonanilidderivat und arzneimittel.
DE69029693D1 (de) Hydantoin- oder Imidazolidintrionderivate zur Vorbeugung oder Behandlung von Niereninsuffizienz
BR9503572A (pt) Composto composiçao farmaceutica e método de tratamento ou prevençao de uma doença
BR9608413A (pt) Inibidor de edema cerebral
WO2001091796A8 (en) Methods, compounds and compositions for treating gout
NO975726D0 (no) N-Hydroksyurea-derivater som anti-inflammatoriske midler
NO971743L (no) Farmasöytisk sammensetning for profylakse og behandling av type I allergiske sykdommer
ES2140531T3 (es) Inhibidor de la interleucina-1.
ES2191763T3 (es) Inhibidor del desarrollo de dependencia/tolerancia a un agente analgesico narcotico.
DE69620573D1 (de) Mittel zur verminderung des augeninnendrucks
DE69327077D1 (de) Carbamoylpyrrolidon-Derivate zur Behandlung von Depressionen und cerebrovasculären Störungen
RU93058386A (ru) Противовирусная комбинация, содержащая неуклеозидный аналог, фармацевтическая композиция, способ лечения
EP0811620A4 (de) Phenylamidinothiophenderivate und diese enthaltende antiphlogistische mittel

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties